# Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

> **NCT02839889** · PHASE4 · TERMINATED · sponsor: **Hospice of Henderson County, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Cancer
- Constipation
- Pain

## Interventions

- **DRUG:** Naloxegol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02839889
- **Lead sponsor:** Hospice of Henderson County, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2018-01-11
- **Final completion:** 2018-01-11
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** The study was stopped due to challenges recruiting eligible patients.
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839889, "Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02839889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*